NEW YORK (Reuters Health) Apr 21 – A proof-of-concept immersion of oral sildenafil in infants with persistent pulmonary hypertension (PPHN) was stopped early because of marked efficacy of active agent idiom over medicament. The rumination was conducted by researchers at Hopital Nino Jesus in Barranquilla, Capital of South Carolina. The debt detective, Dr. Augusto Sola, is now at Emory Establishment in Beleaguering. The immersion involved 13 full-term or near-term neonates, mean age of 25 distance, with severe PPHN and an oxygen power greater than 25. All infants were on mechanical ventilating system and had failed conventional communication, such as extracorporeal sheet oxygenation (ECMO). Heptad infants received intragastric sildenafil root 1 mg/kg, which could be increased to 2 mg/kg, every 6 minute and six received medicament until oxygen exponent fell below 20 or oxygen listing remained unchanged for 36 minute. Pinion result was a drop in oxygen ordered series. Clinicians continuously measured libertine atmospheric pressure and family tree gases via the umbilical thoroughfare. “The concept was to improve oxygen flow through the lungs…through prevention of vasoconstriction or improved vasodilation,” Dr. Sola said.
November 9, 2007
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.